Ke Wang

1PUBLICATIONS
4CO-AUTHORS
Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 16, 2024
Real-world application of disitamab vedotin (RC48-ADC) in patients with breast cancer with different HER2 expression levels: efficacy and safety analysis.

Ke Wang, Ting Xu, Jing Wu

Pageof 1

Frequent Collaborators

1 joint publications

Ting Xu

1 joint publications

Yuan Yuan

1 joint publications

Xiaoxiang Guan

1 joint publications

Chengjun Zhu